As of January 23, 2025, Evoke Pharma (EVOK) has a market cap of $6.390 million USD. According to our data, Evoke Pharma is ranked No.8988 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $6.39 M |
-2.71%
|
Dec 31, 2024 | $6.57 M |
-64.92%
|
Dec 29, 2023 | $18.72 M |
-60.82%
|
Dec 30, 2022 | $47.79 M |
-59.39%
|
Dec 31, 2021 | $0.12 B |
-78.68%
|
Dec 31, 2020 | $0.55 B |
59.26%
|
Dec 31, 2019 | $0.35 B |
-34.68%
|
Dec 31, 2018 | $0.53 B |
9.73%
|
Dec 29, 2017 | $0.48 B |
11.88%
|
Dec 30, 2016 | $0.43 B |
-38.79%
|
Dec 31, 2015 | $0.71 B |
-44.07%
|
Dec 31, 2014 | $1.26 B |
-20.81%
|
Dec 31, 2013 | $1.59 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Ironwood Pharmaceuticals
IRWD
|
$0.60 B |
0.000 M
|
USA
|
Pacira Biosciences
PCRX
|
$1.04 B |
-0.000 M
|
USA
|
Collegium Pharmaceutical
COLL
|
$1.05 B |
0.000 M
|
USA
|
Assertio Therapeutics
ASRT
|
$77.34 M |
-0.000 M
|
USA
|
Cara Therapeutics
CARA
|
$21.85 M |
0.000 M
|
USA
|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
Trevena
TRVN
|
$1.61 M |
0.000 M
|
USA
|
Supernus Pharmaceuticals
SUPN
|
$2.11 B |
-0.000 M
|
USA
|
Aquestive Therapeutics
AQST
|
$0.29 B |
-0.000 M
|
USA
|
Market Cap | = | EVOK Stock Price | * | EVOK Shares Outstanding |
= | $4.30 | * | 1.49 M | |
= | $6.39 M |